Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05630729 · ClinicalTrials.gov registry record · NA
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
A NA study of Chronic Kidney Diseases and Chronic Kidney Disease Stage 3, sponsored by 3-C Institute for Social Development.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 2
- Study locations
NCT05630729: Completed NA study of Chronic Kidney Diseases and Chronic Kidney Disease Stage 3, sponsored by 3-C Institute for Social Development.
NCT05630729 is a NA study of Chronic Kidney Diseases and Chronic Kidney Disease Stage 3 that has completed, run by 3-C Institute for Social Development. The registered enrollment target is 67 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05630729, a NA study of Chronic Kidney Diseases and Chronic Kidney Disease Stage 3, has completed, sponsored by 3-C Institute for Social Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 2
- Study locations
Study Summary
Leveraging a unique combination of synchronized web and mobile applications, this 3 year SBIR Phase II project will fully develop and pilot test My Kidney Guru-a program that will offer pediatric patients with CKD developmentally appropriate, interactive, and engaging instruction and practice opportunities to build knowledge and skills to manage CKD.
Primary Outcome
Both parents and adolescents will complete this 18-item measure, rating the extent to which youth are ready to transition to self-care and manage their health-related needs independently. Items assess adolescents' independence in scheduling doctor's appointments, remembering to take medication, finding answers to health-related questions, knowledge of their condition, and how easy/difficult these tasks are for the youth. Responses range from 0 (Never, Very Hard, or Nothing) to 5 (Always, Very Ea
Conditions Studied
Interventions
- OTHER My Kidney Guru
Study Locations (2)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
- 3C Institute - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
What the finished NCT05630729 record still lists
NCT05630729 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (85% lower).
The record links to 9 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which My Kidney Guru is the first listed.
NCT05630729 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05630729 about?
NCT05630729 is a clinical study titled "Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management". Leveraging a unique combination of synchronized web and mobile applications, this 3 year SBIR Phase II project will fully develop and pilot test My Kidney Guru-a program that will offer pediatric patients with CKD developmentally appropriate, interactive, and engaging instruction and practice opport...
What is the current status of trial NCT05630729?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2021-09-01. Estimated completion is 2022-07-31.
What conditions does trial NCT05630729 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Chronic Kidney Disease Stage 3, Pediatric Kidney Disease, Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 4.
What interventions are being tested in trial NCT05630729?
The interventions under investigation include: My Kidney Guru (OTHER).
Who is sponsoring clinical trial NCT05630729?
This trial is sponsored by 3-C Institute for Social Development, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05630729 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05630729's enrollment target sits among peer trials
67 49th of 73 higher than 25 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
-
Handgrip Exercise Training and CKD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI